800 million time and space: it is planned to buy back shares of 50 million yuan to 100 million yuan. According to the announcement of 800 million time and space, it is planned to buy back shares of 50 million yuan to 100 million yuan. The source of funds is the company's own funds and the special loan for stock repurchase provided by CITIC Bank Beijing Branch, in which the amount of special loan does not exceed 70 million yuan. The repurchased shares are used for employee stock ownership plans or equity incentives at an appropriate time in the future. The repurchase price shall not exceed 41 yuan/share.Hanwang Technology: There are no major matters that should be disclosed but not disclosed about the Company, and Hanwang Technology has issued a change announcement. There are no major matters that should be disclosed but not disclosed about the Company, the controlling shareholder and the actual controller, or major matters in the planning stage; The company's disclosed operating conditions and internal and external operating environment have not changed significantly.USD/JPY rose more than 0.50% in the day and is now reported at 150.63.
Market News: Egypt condemns Israel's "further occupation of Syrian land" and believes that entering the buffer zone is an attempt to force a new reality on the ground.Zhongtai Futures: Wu Xiuwei has been appointed as the joint company secretary, Zhongtai Futures (01461) announced that Wei Weifeng resigned as the joint company secretary of the company and the company's agent (legal process agent) for receiving legal process documents and notices in China and Hong Kong according to Part 16 of the Companies Ordinance, Chapter 622 of the Laws of Hong Kong, with effect from December 10, 2024. Wu Xiuwei has been appointed as the joint company secretary and legal representative, with effect from December 10, 2024.Market news: Putin will extend the permission of some Russian companies not to consider voting by shareholders from unfriendly countries until the end of 2025.
Ramsden, deputy governor of the Bank of England: The relatively calm market conditions this year may lead to greater risks in the future; In view of the increasing uncertainty of the future, we must continue to be vigilant; We should monitor and evaluate the risks in the UK financial market and make use of our balance sheet when appropriate.About 40% of South Korea's stock prices hit a new low in the year, and the exchange rate of the won against the US dollar fell for four consecutive trading days. Today is the first trading day after the abolition of the impeachment motion of the South Korean President. Due to political instability, the financial market in South Korea fluctuated violently today. The Korea Composite Stock Index closed at 2360.58 points, down 2.78% from the previous trading day, and closed down for four consecutive trading days. Statistics show that about 40% of the stocks listed on South Korea's main board and Growth Enterprise Market today hit a new low this year. In addition, the exchange rate of the Korean won has also dropped simultaneously today. At the close, the exchange rate of the Korean won against the US dollar was 1,437 won to the US dollar, and the closing price hit the lowest value in more than two years for four consecutive trading days. (CCTV Finance)National Medical Products Administration publicly solicited opinions on the Announcement (Draft for Comment) on Simplifying the Registration and Approval of Traditional Oral Chinese Patent Medicines Listed in Hong Kong and Macao on the Mainland. According to the website of National Medical Products Administration, in order to implement the strategic plan of national construction in Guangdong-Hong Kong-Macao Greater Bay Area, further support the development of Chinese medicine in the Hong Kong Special Administrative Region and the Macao Special Administrative Region, and better integrate into the overall situation of national development, National Medical Products Administration drafted the Announcement (Draft for Comment) on Simplifying the Registration and Approval of Traditional Oral Chinese Patent Medicines Listed in Hong Kong and Macao on the Mainland, which is now open to the public for comments.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13